In order to meet this moment marked by the rise of GLP-1s, we know what that looks like
Efficacy and Safety of Once-Weekly Semaglutide Monotherapy Versus Placebo in Patients With Type 2 Diabetes (SUSTAIN 1): A Double-Blind, Randomised, Placebo-Controlled, Parallel-Group, Multinational, Multicentre Phase 3a Trial
Reflecting on those times, she shared, "I tried any fad weight loss trend except for the real thing that actually works, and that's a lifestyle change." Her journey has led her to a healthier, more sustainable weight-loss approach
FDA has documented adverse events including overdoses from dosing errors - get explicit measurement guidance from provider before first injection FTC precedent: FTC December 2025 NextMed enforcement action involved undisclosed GLP-1 subscription costs
Tissue Repair and Regenerative Peptides Regenerative peptide research has accelerated significantly in the past decade, driven by demand for novel interventions in wound healing, tendon repair, gut mucosal restoration, and inflammatory disease models